Stellate Ganglion Block
Recruiting
Phase 4
Interventional Study
Esophagectomy
Pneumonectomy
Lobectomy
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 85
- Sex
- Any
- Trial phase
- Phase 4
- Study type
- Interventional
- Purpose
- Prevention
- Participants needed
- 48 (estimated)
- Sponsor
- University of Minnesota · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to determine if the addition of an ultrasound guided left sided stellate ganglion block with bupivacaine in patients undergoing esophagectomy, pneumonectomy, or lobectomy will result in lower rates of postoperative atrial fibrillation as compared to standard of care.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Patients undergoing esophagectomy, pneumonectomy, or lobectomy aged 18-85.
Exclusion Criteria:
* Patients who have an exclusion to regional anesthesia.
* Patients who have exclusion to stellate blockade.
* Patients who are pregnant assessed via self-report or pregnancy test …
Contacts